ArticleCommunications biology2026
Proteomic maps of synapses and synaptic vesicles across the central and enteric nervous systems.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
While the synaptic proteome of the central nervous system (CNS) has been extensively characterized, its composition in the peripheral nervous system (PNS) remains unknown. There is an urgent need to delineate the precise proteomic landscape of the enteric nervous system (ENS), often referred to as the "second brain," and to systematically compare its molecular heterogeneity with that of the CNS. To address this, we developed a streamlined workflow integrating subcellular organelle isolation with PulseDIA proteomics, enabling the identification of 13,534 synaptic proteins across the CNS and ENS (including 8807 for ENS). We defined 776 synaptic vesicle-resident proteins in the CNS and 1148 in the ENS. Comparative proteomic analysis revealed a fundamental divergence-convergence relationship: while the two nervous systems exhibit distinct molecular signatures, they maintain conserved functional organization. Furthermore, energy intake restriction in mice induced extensive ENS proteome remodeling. Pharmacological inhibition of FGFR1 kinase activity suppressed thermogenesis independently of energy substrate utilization, suggesting FGFR1's potential role in ENS-mediated energy metabolism regulation. Collectively, our study provides a resource for neurobiological and neurological research and elucidates proteomic divergences and convergences between the CNS and ENS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.